Public stock analysis · DK0062498333
Analyse Novo Nordisk stock
StocksterScore94
94
Current overview
Metrics for Novo Nordisk
Current course33,11 €
StocksterScore94/ 100
Analyst potential+22%
AI price target40,40 €
AI Analysis (Teaser)
AI analysis for Novo Nordisk
Confirmed
36.12 EUR is around -16.8% below the current price of 43.43 EUR and therefore within the required plausibility range of +/-25%.
Quantitative: The specified P/E ratio of 14.21 works for Novo Nordisk rather moderate in the historical and sectoral context; At the same time, the distance to the 52W high of EUR 62.43 already signals a clear normalization of valuations. A price target of EUR 36.12 does not imply a stress rating, but rather a conservative multiple in the event of slowing growth, margin pressure or regulatory risk.
Fundamental: Novo Nordisk remains qualitatively strong with high profitability, robust c...
36.12 EUR is around -16.8% below the current price of 43.43 EUR and therefore within the required plausibility range of +/-25%.
Quantitative: The specified P/E ratio of 14.21 works for Novo Nordisk rather moderate in the historical and sectoral context; At the same time, the distance to the 52W high of EUR 62.43 already signals a clear normalization of valuations. A price target of EUR 36.12 does not imply a stress rating, but rather a conservative multiple in the event of slowing growth, margin pressure or regulatory risk.
Fundamental: Novo Nordisk remains qualitatively strong with high profitability, robust c...
AI analysis updated on October 5, 2026